Rheumatic diseases and chronic myelogenous leukemia, presentation of four cases and review of the literature

Rheumatology International

Volumn 26, Issue 9, 2006, Pages 857-861

  Senel, Soner ^a   Kaya, Emin ^a   Aydogdu, Ismet ^a   Erkurt, M Ali ^a   Kuku, Irfan ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

Behcet's disease; Chronic myelogenous leukemia; Diffuse cutaneous systemic sclerosis; Rheumatic disease; Rheumatoid arthritis

Indexed keywords

ALPHA2A INTERFERON; COLCHICINE; GLUCOCORTICOID; HYDROXYCHLOROQUINE; HYDROXYUREA; IMATINIB; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ACNE; ADULT; AGED; APHTHOUS ULCER; BEHCET DISEASE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG ERUPTION; DRUG SUBSTITUTION; FEMALE; GENITAL ULCER; HUMAN; LEUKOCYTOSIS; MEDICAL LITERATURE; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SCLERODERMA; SPONDYLOARTHROPATHY;

ADULT; AGED; BEHCET SYNDROME; FEMALE; HUMANS; HYDROXYUREA; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, CHRONIC; MIDDLE AGED; RHEUMATIC DISEASES; SCLERODERMA, SYSTEMIC; SPONDYLARTHRITIS;

EID: 33745059043     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-005-0100-5     Document Type: Review

References (25)

1. Sillaber C, Mayerhofer M, Agis H, et al. (2003) Chronic myeloid leukemia: pathophysiology, diagnostic parameters, and current treatment concepts. Wien Klin Wochenschr 115:485-504
2. Valeriano J (1997) Malignancy and rheumatic disease. Cancer Control 3:236-244
3. Thomas E, Brewster DH, Black RJ, Macfarlane GJ (2000) Risk of malignancy among patients with rheumatic conditions. Int J Cancer 88:497-502
4. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, Cats A, Dijkmans B, Olivieri I, Pasero G, et al. (1991)The European spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34:1218-1227
5. Kataria RK, Brent LH (2004) Spondyloarthropathies. Am Fam Physician 69:2853-2860
6. Karincaoglu Y, Kaya E, Esrefoglu M, Aydogdu I (2003) Development of large genital ulcer due to hydroxyurea treatment in a patient with chronic myeloid leukemia and Behcet's disease. Leuk Lymphoma 44:1063-1065
7. Budak-Alpdogan T, Alpdogan O, Direskeneli H, et al. (1998) Skin hyperreactivity of Behçet's patients (pathergy reaction) is also positive in interferon alpha-treated chronic myeloid leukemia patients, indicating similarly altered neuthrophil functions in both disorders. Br J Rheumatol 37:1148-1151
8. Budak-Alpdogan T, Demircay Z, Alpdogan O, et al. (1997) Behcet's disease in patients with chronic myelogenous leukemia: possible role of interferon-alpha treatment in the occurrence of Behcet's symptoms. Ann Hematol 74:45-48
9. Raanani P, Ben-Bassat I (2002) Immune-mediated complications during interferon therapy in hematological patients. Acta Haematologica 107:133-144
10. Sacchi S, Talpaz M (1995) Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemia. J Clin Oncol 13:2401-2407
11. Abe T, Imai K, Tokunoh T et al (1995) Case report: rheumatoid arthritis complicated by chronic myelogenous leukemia treated with interferon. Nihon Rinsho Meneki Gakkai Kaishi 18:70-75
12. Pointud P, Prudat M, Peron JM (1993) Acute leukemia after low dose methotrexate therapy in apatient with rheumatoid arthritis. J Rheumatol 20:1215-1216
13. Dubin Kerr L, Troy K, Isola L (1995) Temporal association between the use of methotrexate and development of leukemia in two patients with rheumatoid arthritis. J Rheumatol 22:2356-2358
14. Choi BR, Ahn MJ, Lee WS, Kim TH, Bae SC, Jun JB (2005) Acute erythroleukemia in a rheumatoid arthritis patient during low-dose methotrexate therapy. Rheumatol Int May 25(4):311-313
15. Job-Deslandre C, Menkes CJ, Michalski B, et al. (1985) Rheumatoid polyarthritis, gougerot-sjogren syndrome and chronic myeloid leukemia. Apropos of two cases. Rev Rhum Mal Osteoartic 52:247-249
16. Miyachi K, Ihara A, Hankins RW, et al. (2003) Efficacy of imatinib mesylate (STI571) treatment for a patient with rheumatoid arthritis developing chronic myelogenous leukemia. Clin Rheumatol 22:329-332
17. Kotter I, Muller CA, Einsele H, et al. (1999) Interferon-alpha-associated polyarthritis Possible induction of seropositive rheumatoid arthritis by interferon-alpha: two case reports and review of the literature. Z Rheumatol 58:185-195
18. Georgescu L, Quinn G, Schwartzman S, Paget S (1997) Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment. Semin Arthritis Rheum 26:794-804
19. Matteson EL, Hickey AR, Maguire L, Tilson HH, Urowitz MB (1991) Occurrence of neoplasia in patients with rheumatoid arthritis enrolled in a DMARD registry. J Rheumatol 18:809-814
20. Moder K, Tefferi A, Cohen M, Menke D, Luthra H (1995) Hematologic malignanices and the use of methotrexate in rheumatoid arthritis: a retrospective study. Am J Med 99:276-281
21. Bleyer A (1998) Methotrexate induced lymphoma?. J Rheumatol 25:404-406
22. Roumm AD, Medsger TA (1985) Cancer and systemic sclerosis. Arthritis Rheum 28:1336-1340
23. Watanabe S, Sugihara T, Takahashi M, et al. (1994) Concordant improvement of progressive systemic sclerosis and chronic myelogenous leukemia with interferon-alpha treatment. Rinsho Ketsueki 35:895-897
24. Wooten MD, Scott JW, Miller AM, et al. (1998) Chronic myelogenous leukemia and porphyria cutanea tarda in a patient with limited systemic sclerosis. South Med J 91:493-495
25. Beretta L, Caronni M, Vanoli M, et al. (2002) Systemic sclerosis after interferon-alfa therapy for myeloproliferative disorders. Br J Dermatol 147:385-386